BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28888621)

  • 1. Patient-reported outcomes in acute myeloid leukemia: Where are we now?
    Buckley SA; Kirtane K; Walter RB; Lee SJ; Lyman GH
    Blood Rev; 2018 Jan; 32(1):81-87. PubMed ID: 28888621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis.
    Stauder R; Lambert J; Desruol-Allardin S; Savre I; Gaugler L; Stojkov I; Siebert U; Chevrou-Séverac H
    Eur J Haematol; 2020 May; 104(5):476-487. PubMed ID: 31985078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia.
    Bryant AL; Drier SW; Lee S; Bennett AV
    Leuk Res; 2018 Jul; 70():106-116. PubMed ID: 29925044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
    Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M
    Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment decision-making for older patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: problems and approaches.
    Deschler B; de Witte T; Mertelsmann R; Lübbert M
    Haematologica; 2006 Nov; 91(11):1513-22. PubMed ID: 17082009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
    Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
    Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.
    Wang R; Zeidan AM; Yu JB; Soulos PR; Davidoff AJ; Gore SD; Huntington SF; Gross CP; Ma X
    Prostate; 2017 Apr; 77(5):437-445. PubMed ID: 27868212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 11. Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?
    Cannella L; Caocci G; Jacobs M; Vignetti M; Mandelli F; Efficace F
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):542-54. PubMed ID: 26324461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis.
    Wang P; Liu H; Jiang T; Yang J
    PLoS One; 2015; 10(9):e0137300. PubMed ID: 26340093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia.
    Craddock C; Labopin M; Robin M; Finke J; Chevallier P; Yakoub-Agha I; Bourhis JH; Sengelov H; Blaise D; Luft T; Hallek M; Kröger N; Nagler A; Mohty M
    Haematologica; 2016 Jul; 101(7):879-83. PubMed ID: 27081178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications.
    Efficace F; Lo-Coco F
    Haematologica; 2013 Jan; 98(1):7-9. PubMed ID: 23277592
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span.
    Barot SV; Patel BJ; Gerds AT
    Curr Hematol Malig Rep; 2020 Apr; 15(2):149-154. PubMed ID: 32048198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Wong E; Mason K; Collins J; Hockridge B; Boyd J; Gorelik A; Szer J; Ritchie DS
    Biol Blood Marrow Transplant; 2017 May; 23(5):840-844. PubMed ID: 28167152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly.
    Klepin HD
    Clin Geriatr Med; 2016 Feb; 32(1):155-73. PubMed ID: 26614866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More general incorporation of hemoglobin level into response criteria for myelodysplastic syndrome and acute myeloid leukemia with increase in minimum red cell transfusion levels.
    Halpern AB; Estey EH
    Leuk Lymphoma; 2022 Mar; 63(3):514-517. PubMed ID: 34749576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.